Search

everythinglearnresearchcommunity

for

Search:↓

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Benign skin tumors need accurate diagnosis to ensure proper treatment.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Animal research has greatly advanced dermatology.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Experts discussed hair care, genetic hair defects, hair loss treatments, nail surgery, lupus treatments, skin infections, and cosmetic allergies.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Dermoscopy improves diagnosis of hair and scalp disorders and can help avoid unnecessary biopsies.